Загрузка...
Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome
INTRODUCTION: Treatment of hypercholesterolemia in refractory nephrotic syndrome remains a therapeutic challenge. There is not enough evidence supporting the efficacy of statins, and these drugs can be associated with an increased incidence of adverse effects. Herein we summarize our clinical experi...
Сохранить в:
| Опубликовано в: : | Kidney Int Rep |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7783565/ https://ncbi.nlm.nih.gov/pubmed/33426389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.09.046 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|